<?xml version="1.0" encoding="UTF-8"?>
<table-wrap id="jia225610-tbl-0001" xml:lang="en" content-type="Table" orientation="portrait" position="float">
 <label>Table 1</label>
 <caption>
  <p>Endpoint definitions</p>
 </caption>
 <table frame="hsides" rules="groups">
  <col style="border-right:solid 1px #000000" span="1"/>
  <col style="border-right:solid 1px #000000" span="1"/>
  <col style="border-right:solid 1px #000000" span="1"/>
  <thead valign="top">
   <tr style="border-bottom:solid 1px #000000">
    <th align="left" valign="top" rowspan="1" colspan="1">Primary endpoint</th>
    <th align="left" valign="top" rowspan="1" colspan="1">Definition</th>
    <th align="left" valign="top" rowspan="1" colspan="1">Additional considerations</th>
   </tr>
  </thead>
  <tbody>
   <tr>
    <td align="left" rowspan="1" colspan="1">Retention</td>
    <td align="left" rowspan="1" colspan="1">
     <p>Participant is classified as retained in HIV care if they are a) alive and b) have not stopped treatment, whereby either:</p>
     <list list-type="bullet" id="jia225610-list-0001">
      <list-item>
       <p>[End of the Study Period]‐[Last Visit Date] &lt; 90 days; or</p>
      </list-item>
      <list-item>
       <p>[Next Appointment Date] – [End of the Study Period]&gt; (within 30 days)</p>
      </list-item>
     </list>
     <p>Time to non‐retention was the last date at which the first of the above defining events occurred.</p>
    </td>
    <td align="left" rowspan="1" colspan="1">
     <list list-type="bullet" id="jia225610-list-0002">
      <list-item>
       <p>If the next scheduled visit date is missing, then the next visit date will equal last visit date plus 120 days</p>
      </list-item>
      <list-item>
       <p>For participants who transferred out or stopped treatment, their last visit date was used as their transfer date or stopped treatment date</p>
      </list-item>
     </list>
    </td>
   </tr>
   <tr>
    <td align="left" rowspan="1" colspan="1">Viral suppression</td>
    <td align="left" rowspan="1" colspan="1">
     <p>Participants were excluded if:</p>
     <list list-type="bullet" id="jia225610-list-0003">
      <list-item>
       <p>They were not retained for 180 days following ART initiation; or</p>
      </list-item>
      <list-item>
       <p>They were transferred out of the MaxART trial clinics by 180 days following ART initiation; or</p>
      </list-item>
      <list-item>
       <p>They were never initiated on ART; or</p>
      </list-item>
      <list-item>
       <p>The time between ART initiation and the study end date was &lt;180 days</p>
      </list-item>
     </list>
     <p>Non‐excluded participants were classified as virally unsuppressed when one of the following was true:</p>
     <list list-type="bullet" id="jia225610-list-0004">
      <list-item>
       <p>The first VL measurement was ≥1000 copies/mml; or</p>
      </list-item>
      <list-item>
       <p>They were lost to follow‐up by the end of the study or the clinic transition date; or</p>
      </list-item>
      <list-item>
       <p>They stopped treatment; or</p>
      </list-item>
      <list-item>
       <p>Their death was ART‐ or HIV‐related; or</p>
      </list-item>
      <list-item>
       <p>There was no available VL measurement</p>
      </list-item>
     </list>
    </td>
    <td align="left" rowspan="1" colspan="1">
     <list list-type="bullet" id="jia225610-list-0005">
      <list-item>
       <p>This endpoint assesses viral suppression conditional on ART‐initiation and retention to 180 days post ART initiation date</p>
      </list-item>
      <list-item>
       <p>Time to elevated VL 180 days post‐ART initiation was the date at which the first of these defining events occurred. As such, it is not a randomized endpoint</p>
      </list-item>
      <list-item>
       <p>When one or more VL measurements were available six months or more after ART initiation, we took the last available VL prior to censoring as the event‐defining value, assuming that if suppressed in the future, they were suppressed in the past</p>
      </list-item>
     </list>
    </td>
   </tr>
   <tr>
    <td align="left" rowspan="1" colspan="1">Combined retention and viral suppression</td>
    <td align="left" rowspan="1" colspan="1">
     <p>Defined as:</p>
     <list list-type="bullet" id="jia225610-list-0006">
      <list-item>
       <p>Date when either non‐retention in care or elevated VL occurred, and</p>
      </list-item>
      <list-item>
       <p>Survival time was the minimum of the times from enrolment to any of the events qualifying for either non‐retention or elevated VL</p>
      </list-item>
     </list>
    </td>
    <td align="left" rowspan="1" colspan="1">
     <list list-type="bullet" id="jia225610-list-0007">
      <list-item>
       <p>While this combined endpoint was not one of the original primary endpoints registered for the trial, it offers important insights and was included in the final analysis</p>
      </list-item>
      <list-item>
       <p>The combined endpoint was analysed using an intent‐to‐treat approach</p>
      </list-item>
     </list>
    </td>
   </tr>
  </tbody>
 </table>
 <permissions>
  <copyright-holder>John Wiley &amp; Sons, Ltd</copyright-holder>
 </permissions>
</table-wrap>
